In this modern era, with the help of various advanced technologies, medical science has overcome most of the health-related issues successfully. Though, some diseases still remain …
Barriers are the hallmark of a healthy physiology, blood-brain barrier (BBB) being a tough nut to crack for most of the antigens and chemical substances. The presence of tight …
F Juhairiyah, ECM de Lange - The AAPS Journal, 2021 - Springer
Brain drug delivery may be restricted by the blood-brain barrier (BBB), and enhancement by liposome-based drug delivery strategies has been investigated. As access to the human …
S Parrasia, I Szabò, M Zoratti… - Molecular …, 2022 - ACS Publications
Central nervous system (CNS) diseases are among the most difficult to treat, mainly because the vast majority of the drugs fail to cross the blood-brain barrier (BBB) or to reach …
MM Omar, OA Hasan, AM El Sisi - International journal of …, 2019 - Taylor & Francis
Aim To develop the topical gel containing transferosomal lidocaine as alternative to painful local anesthetic injection. Materials and methods The transfersomes were prepared by film …
F Fernandes, M Dias-Teixeira, C Delerue-Matos… - Nanomaterials, 2021 - mdpi.com
The biggest obstacle to the treatment of diseases that affect the central nervous system (CNS) is the passage of drugs across the blood-brain barrier (BBB), a physical barrier that …
BF Mogharbel, MA Cardoso, AC Irioda, PEF Stricker… - Molecules, 2022 - mdpi.com
Background: Parkinson's disease (PD) is the second most common age-related neurodegenerative disorder. Levodopa (L-DOPA) remains the gold-standard drug available …
Resveratrol (RES) is a potent antioxidant used for the management of several central nervous system diseases. RES bioavailability is less than 1 owing to its low solubility and …
R Vargas, C Lizano-Barrantes, M Romero… - International Journal of …, 2024 - Elsevier
Abstract The Blood-Brain Barrier (BBB) significantly impedes drug delivery to the central nervous system. Nanotechnology, especially surface-functionalized lipid nanoparticles …